Isabela Reis Marques

Isabela Reis Marques

Auto-generated profile, based on publicly available information

Isabela Reis Marques

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
AGAmanda Godoi
Amanda Godoi
IMIsabela Reis Marques
Isabela Reis Marques
EPEduardo M. H. Padrão
Eduardo M. H. Padrão
AMAshwin Mahesh
Ashwin Mahesh
LHLarissa C. Hespanhol
Larissa C. Hespanhol
JSJoao Roberto De Sa
Joao Roberto De Sa
Background: Glycaemic control of Type 1 Diabetes Mellitus (T1DM) remains a challenge due to hypoglycaemic episodes and the burden of insulin self-management. Advancements have been made with the development of automated insulin delivery (AID) devices, yet, previous reviews have only assessed the use of AID over days or weeks, and potential benefits with longer time of AID use in this population remain unclear. Methods: We performed a systematic review and meta-analysis of randomised controlled trials comparing AID (hybrid and fully closed-loop systems) to usual care (sensor augmented pumps, multiple daily insulin injections, continuous glucose monitoring and predictive low-glucose suspend) for adults and children with T1DM with a minimum duration of 3 months. We searched PubMed, Embase, Cochrane Central, and Clinicaltrials.gov for studies published up until April 4, 2023. Main outcomes included time in range 70–180 mg/dL as the primary outcome, and change in HbA1c (%, mmol/mol), glucose variability, and psychosocial impact (diabetes distress, treatment satisfaction and fear of hypoglycaemia) as secondary outcomes. Adverse events included diabetic ketoacidosis (DKA) and severe hypoglycaemia. Statistical analyses were conducted using mean differences and odds ratios. Sensitivity analyses were performed according to age, study duration and type of AID device. The protocol was registered in PROSPERO, CRD42022366710. Results: We identified 25 comparisons from 22 studies (six crossover and 16 parallel designs) including a total of 2376 participants (721 in adult studies, 621 in paediatric studies, and 1034 in combined studies) which were eligible for analysis. Use of AID devices ranged from 12 to 96 weeks. Patients using AID had 10.87% higher time in range [95% CI 9.38 to 12.37; p < 0.0001, I2 = 87%) and 0.37% (4.77 mmol/mol) lower HbA1c (95% CI − 0.49% (− 6.39 mmol/mol) to – 0.26 (− 3.14 mmol/mol); p < 0·0001, I2 = 77%]. AID systems decreased night hypoglycaemia, time in hypoglycaemia and hyperglycaemia and improved patient distress, with no increase in the risk of DKA or severe hypoglycaemia. No difference was found regarding treatment satisfaction or fear of hypoglycaemia. Among children, there was no difference in glucose variability or time spent in hypoglycaemia between the use of AID systems or usual care. In sensitivity analyses, results remained consistent with the overall analysis favouring AID. Conclusion: The use of AID systems over 12 weeks, regardless of technical or clinical differences, improved glycaemic outcomes and diabetes distress without increasing the risk of adverse events in adults and children with T1DM.

17 July 2023 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
YMYasmin Luz Lima de Mesquita
Yasmin Luz Lima de Mesquita
ICIzabela Pera Calvi
Izabela Pera Calvi
IMIsabela Reis Marques
Isabela Reis Marques
SCSara Almeida Cruz
Sara Almeida Cruz
EPEduardo Messias Hirano Padrao
Eduardo Messias Hirano Padrao
VRVladimir Vitalievich Rafalskiy
Vladimir Vitalievich Rafalskiy

26 July 2023 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
PAPriscila P. Andrade
Priscila P. Andrade
RLRafael A. Lombardi
Rafael A. Lombardi
IMIsabela R. Marques
Isabela R. Marques
ABAnna Carla Di Napoli Andrade e Braga
Anna Carla Di Napoli Andrade e Braga
BIBeatrice R.S. Isaias
Beatrice R.S. Isaias
NHNicholas E. Heiser
Nicholas E. Heiser
This study compares Fascia Iliaca compartment (FI) block and Pericapsular Nerve Group (PENG) block for hip surgery. Pubmed, Embase and Cochrane were systematically searched in April 2022. Inclusion criteria were: Randomized Controlled Trials (RCTs); comparing PENG block versus FI block for hip surgery; patients over 18 years of age; and reporting outcomes immediately postoperative. We excluded studies with overlapped populations and without a head-to-head comparison of the PENG block vs. FI block. Mean-Difference (MD) with 95% Confidence Intervals (CI) were pooled. Trial Sequential Analyses (TSA) were performed to assess inconsistency. Quality assessment and risk of bias were performed according to Cochrane recommendations. Eight RCTs comprising 384 patients were included, of whom 196 (51%) underwent PENG block. After hip surgery, PENG block reduced static pain score at 12h post-surgery (MD = 0.61 mm; 95% CI 1.12 to -0.09; p = 0.02) and cumulative postoperative oral morphine consumption in the first 24h (MD = -6.93 mg; 95% CI -13.60 to -0.25; p = 0.04) compared with the FI group. However, no differences were found between the two techniques regarding dynamic and static pain scores at 6 h or 24 h post-surgery, or in the time to the first analgesic rescue after surgery. The findings suggest that PENG block reduced opioid consumption in the first 24 h after surgery and reduced pain scores at rest at 12 h post-surgery. Further research is needed to fully understand the effects of the PENG block and its potential benefits compared to FI block. CRD42022339628 PROSPERO REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=339628.

6 September 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
IMIsabela R. Marques
Isabela R. Marques
ICIzabela P. Calvi
Izabela P. Calvi
SCSara A. Cruz
Sara A. Cruz
LSLuana M. F. Sanchez
Luana M. F. Sanchez
IBIsis F. Baroni
Isis F. Baroni
PMPaula C. Mari
Paula C. Mari

23 October 2023 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
RSRenan Yuji Ura Sudo
Renan Yuji Ura Sudo
MCMaria Carrijo Cunha Câmara
Maria Carrijo Cunha Câmara
SKSofia Vezzani Kieling
Sofia Vezzani Kieling
IMIsabela Reis Marques
Isabela Reis Marques
YMYasmin Mesquita
Yasmin Mesquita
PMPaula Chaves Mari
Paula Chaves Mari